REG - DCC PLC - Director Declaration
RNS Number : 3094UDCC PLC28 March 2019
28 March 2019
Director Declaration
DCC plc, the leading international sales, marketing and support services group, has been notified that Mr. Mark Breuer, a non-executive Director of DCC plc, has been appointed as non-executive director of Arix Bioscience plc with effect from 25 April 2019.
This notification is made pursuant to Listing Rule 9.6.14 of the Listing Rules of the Financial Conduct Authority.
Enquiries:
Gerard Whyte
Company Secretary
Tel +353 1 2799 400
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.ENDRDNDMGZFRRVGLZG
Recent news on DCC
See all newsREG - Morgan Stanley & Co. DCC PLC - Rule 38.5_A- Replacement of DCC Plc
AnnouncementREG-Marathon Asset Management Ltd Form 8.3 - Amendment
AnnouncementREG - BlackRock Group DCC PLC - Form 8.3 - DCC PLC
AnnouncementREG - Keyridge Asset Mgmnt DCC PLC - Form 8.3 (DCC PLC)
AnnouncementREG - BlackRock Group DCC PLC - Form 8.3 - DCC PLC
Announcement